āĻšā§āĻŽSBHMY âĸ OTCMKTS
add
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
⧍ā§Ļ.ā§§ā§Ŧ$
⧧⧍ āϏā§āĻĒ, ⧧⧍:⧍ā§Ļ:ā§¨ā§Š AM GMT -ā§Ē · USD · OTCMKTS · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
⧍ā§Ļ.ā§§ā§Ŧ$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§.ā§§ā§Ģ$ - ⧍ā§Ļ.ā§§ā§Ŧ$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§§ā§Ŧā§§.⧝⧧āĻā§ HKD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§Ēā§Š.ā§Ļā§Ļ
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(CNY) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§Žā§ā§Ž.ā§ā§Ē āĻā§ | ā§§ā§Ļ.ā§ā§§% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Ģā§Ģā§Ē.⧍ā§Ŧ āĻā§ | ā§§ā§Ģ.⧝ā§Ŧ% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§§ā§Ŧ⧝.ā§Ēā§ŠÂ āĻā§ | ⧧⧍.ā§Šā§§% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ⧧⧝.ā§¨ā§Ž | ā§§.ā§Ē⧍% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | â | â |
EBITDA | ⧧⧝ā§.ā§ā§§Â āĻā§ | ā§Ļ.ā§Ļā§Ž% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§§ā§Ŧ.ā§Ēā§Ģ% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(CNY) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ⧧⧝.ā§Žā§¨āĻļāĻ¤Â āĻā§ | ā§Ģā§Ļ.ā§Ēā§§% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§ā§Ē.ā§Žā§¯āĻļāĻ¤Â āĻā§ | ⧧⧍.ā§¨ā§Ž% |
āĻŽā§āĻ āĻĻāĻžā§ | ⧍⧝.⧧⧍āĻļāĻ¤Â āĻā§ | ā§§ā§Ž.ā§Ēā§Ģ% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Ēā§Ģ.ā§ā§ŽāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§Ž.ā§Ļā§ĻāĻļāĻ¤Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§§ā§Ļ.⧝ā§Ļ | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ģ.ā§Ŧ⧝% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§.ā§Šā§Ž% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(CNY) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§§ā§Ŧ⧝.ā§Ēā§ŠÂ āĻā§ | ⧧⧍.ā§Šā§§% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | â | â |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | â | â |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | â | â |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | â | â |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| â | â |
āϏāĻŽā§āĻĒāϰā§āĻā§
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices â MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Groupâs principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧍ā§Ļā§Ļā§Ļ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§¨ā§Š,ā§Ļā§Ģā§Ŧ